EMEA-002317-PIP02-21 - paediatric investigation plan

Invimestrocel

Key facts

• Active Substance:
  Invimestrocel
• Therapeutic area:
  Neurology
• Decision number:
  P/0137/2022
• PIP number:
  EMEA-002317-PIP02-21
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Treatment of ischaemic stroke
• Route(s) of administration:
  Intravenous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  13/04/2022

Decision

P/0137/2022 : EMA decision of 13 April 2022 on the agreement of a paediatric investigation plan and on the granting of a deferral for invimestrocel (EMEA-002317-PIP02-21)

AdoptedReference Number: EMA/157573/2022